JP2020532531A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532531A5
JP2020532531A5 JP2020512411A JP2020512411A JP2020532531A5 JP 2020532531 A5 JP2020532531 A5 JP 2020532531A5 JP 2020512411 A JP2020512411 A JP 2020512411A JP 2020512411 A JP2020512411 A JP 2020512411A JP 2020532531 A5 JP2020532531 A5 JP 2020532531A5
Authority
JP
Japan
Prior art keywords
nitric oxide
ino
oxide according
administered
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020512411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532531A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/048526 external-priority patent/WO2019046415A1/en
Publication of JP2020532531A publication Critical patent/JP2020532531A/ja
Publication of JP2020532531A5 publication Critical patent/JP2020532531A5/ja
Pending legal-status Critical Current

Links

JP2020512411A 2017-08-30 2018-08-29 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用 Pending JP2020532531A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762552022P 2017-08-30 2017-08-30
US62/552,022 2017-08-30
US201762611325P 2017-12-28 2017-12-28
US62/611,325 2017-12-28
PCT/US2018/048526 WO2019046415A1 (en) 2017-08-30 2018-08-29 USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISEASE

Publications (2)

Publication Number Publication Date
JP2020532531A JP2020532531A (ja) 2020-11-12
JP2020532531A5 true JP2020532531A5 (https=) 2021-10-07

Family

ID=65526008

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020512411A Pending JP2020532531A (ja) 2017-08-30 2018-08-29 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用
JP2020512022A Pending JP2020532521A (ja) 2017-08-30 2018-08-29 右室及び/又は左室機能の改善のための吸入用一酸化窒素の使用
JP2023080033A Pending JP2023100985A (ja) 2017-08-30 2023-05-15 右室及び/又は左室機能の改善のための吸入用一酸化窒素の使用
JP2024209997A Pending JP2025029093A (ja) 2017-08-30 2024-12-03 右室及び/又は左室機能の改善のための吸入用一酸化窒素の使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020512022A Pending JP2020532521A (ja) 2017-08-30 2018-08-29 右室及び/又は左室機能の改善のための吸入用一酸化窒素の使用
JP2023080033A Pending JP2023100985A (ja) 2017-08-30 2023-05-15 右室及び/又は左室機能の改善のための吸入用一酸化窒素の使用
JP2024209997A Pending JP2025029093A (ja) 2017-08-30 2024-12-03 右室及び/又は左室機能の改善のための吸入用一酸化窒素の使用

Country Status (14)

Country Link
US (2) US20200188319A1 (https=)
EP (2) EP3675719A4 (https=)
JP (4) JP2020532531A (https=)
KR (1) KR20200083443A (https=)
CN (3) CN111372577A (https=)
AU (2) AU2018324004A1 (https=)
BR (1) BR112020004205A2 (https=)
CA (4) CA3266320A1 (https=)
IL (2) IL272308A (https=)
MX (2) MX2020002194A (https=)
PH (1) PH12020500197A1 (https=)
SG (1) SG11202000893QA (https=)
TW (3) TW201919590A (https=)
WO (2) WO2019046413A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019016708B1 (pt) 2017-02-27 2024-01-30 Third Pole, Inc Sistemas de geração de óxido nítrico
WO2018157175A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
CN113795291A (zh) * 2019-01-14 2021-12-14 背勒丰治疗公司 Pde-5抑制剂和吸入的一氧化氮的组合药物疗法
EP3969416A4 (en) 2019-05-15 2023-11-01 Third Pole, Inc. SYSTEMS AND DEVICES FOR GENERATING NITROGEN OXIDE
CN114269685A (zh) 2019-05-15 2022-04-01 第三极股份有限公司 用于一氧化氮生成的电极
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
US12239460B2 (en) 2020-05-06 2025-03-04 Janssen Pharmaceuticals, Inc. Controlling operation of drug administration devices using surgical hubs
JP2023527463A (ja) * 2020-05-29 2023-06-28 ベレロフォン・セラピューティクス 気体状薬剤のパルス式送達方法
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
EP4405019A4 (en) 2021-09-23 2025-07-16 Third Pole Inc SYSTEMS AND METHODS FOR PROVIDING NITRIC OXIDE
WO2023201363A2 (en) 2022-04-14 2023-10-19 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE025355T2 (en) * 2006-12-12 2016-02-29 Gilead Sciences Inc Composition for treating pulmonary hypertension
WO2009048521A1 (en) * 2007-10-11 2009-04-16 Duke University Potentiating the effect of compound comprising nitric oxide
KR20170005155A (ko) * 2008-01-31 2017-01-11 반더빌트유니버시티 폐의 용태에 따른 치료 방법
AU2009202685B1 (en) * 2009-06-30 2010-08-19 Ino Therapeutics Llc Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
CA2819854A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
WO2013181322A1 (en) * 2012-05-31 2013-12-05 Ino Therapeutics Llc Methods of administering nitric oxide to arterial or arterialized blood
US9795756B2 (en) * 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
TR201707036T4 (en) * 2012-12-04 2018-11-21 Ino Therapeutics Llc Cannula to minimize dose dilution during administration of nitric oxide
US9381212B2 (en) * 2014-01-10 2016-07-05 Mallinckrodt Hospital Products IP Limited Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
CN106572813B (zh) * 2014-03-28 2020-07-17 沙普医疗系统公司 用于量化慢性疾病的多种可能形式对被报告呼吸困难的患者的贡献的可能性的模式识别系统
JP2019506259A (ja) * 2015-12-11 2019-03-07 ベロ バイオテック エルエルシー 線維症に対処するために一酸化窒素を含むガスを投与するための方法及び装置
EP3397331A4 (en) * 2015-12-28 2019-08-21 Vero Biotech LLC METHOD AND APPARATUS FOR ADMINISTERING NITRIC OXIDE WITH ADDITIONAL MEDICAMENTS
US10398820B2 (en) * 2016-02-12 2019-09-03 Mallinckrodt Hospital Products IP Limited Use and monitoring of inhaled nitric oxide with left ventricular assist devices

Similar Documents

Publication Publication Date Title
JP2020532531A5 (https=)
JP2020033360A5 (https=)
JP2020532521A5 (https=)
MX2019006938A (es) Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon.
JP2025510368A5 (https=)
RU2010132581A (ru) Способы терапии заболеваний легких
JP2016516016A5 (https=)
JP2025510912A5 (https=)
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2023522010A5 (https=)
JP2016520089A5 (https=)
JP2020520963A5 (https=)
JP2015522603A5 (https=)
JP2023523557A5 (https=)
JP2018526459A5 (https=)
JP2017508737A5 (https=)
JP2017061488A5 (https=)
CN105412118B (zh) 治疗急慢性呼吸困难的西药组合物及其制备方法
MX2023002156A (es) Acido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentan o-1-carboxilico y derivados del mismo para su uso en el tratamiento de enfermedades de las vias respiratorias.
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
JP2017511307A5 (https=)
Bordier Sleep apnoea in patients with heart failure: part II: therapy
Bednarek Overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea
Sachdeva et al. Comparison of active cycle of breathing technique and pursed lip breathing with Thera Pep® in patients with acute exacerbation of COPD
JP2018502168A5 (https=)